ask="11.3000"
ask_size="1000"
average_daily_volume="31334"
bid="7.8500"
bid_size="200"
book_value="3.3400"
change="+0.0001"
change_from_200_day_moving_average="1.9067"
change_from_50_day_moving_average="1.3442"
change_from_52_week_high="-1.2870"
change_From_52_week_low="4.9801"
change_in_percent="+0.0012%"
close="8.5001"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.2620"
ebitda="-50.28M"
eps_estimate_current_year="-2.6000"
eps_estimate_next_quarter="-0.6300"
eps_estimate_next_year="-2.8500"
ex_dividend_date="N/A"
float_shares="686000"
high="8.7400"
high_52_weeks="9.7871"
last_trade_date="2/8/2017"
last_trade_price="8.5001"
last_trade_size="400"
last_trade_time="3:59pm"
low="8.3900"
low_52_weeks="3.5200"
market_capitalization="180.88M"
moving_average_200_day="6.5934"
moving_average_50_day="7.1559"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.2500"
open="8.3900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+28.9191%"
percent_change_from_50_day_moving_average="+18.7843%"
percent_change_from_52_week_high="-13.1500%"
percent_change_from_52_week_low="+141.4801%"
previous_close="8.5000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.5449"
price_per_sales="34.7839"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.9200"
stock_exchange="NMS"
symbol="NBRV"
volume="14184"
weeks_range_52="3.5200 - 9.7871"
